Searchable abstracts of presentations at key conferences in endocrinology

ea0063s17.3 | Where do pituitary tumours come from? | ECE2019

‘From Lab to Clinic – Can we translate into effective therapeutics’

Kamenicky Peter

The first line treatment of somatotroph adenomas is pituitary surgery, that aims at removing the tumor, but which is frequently incomplete, as invasion into cavernous sinuses often limits the surgical resection. Multimodal medical treatment, which is burdensome, very expensive and has variable therapeutic efficacy, is currently required in more than 60% of the patients. New therapeutic approaches are therefore necessary for controlling hormone secretion, tumor development and ...

ea0081rc4.8 | Rapid Communications 4: Pituitary and Neuroendocrinology 1 | ECE2022

Impaired insulin secretion without changes in insulin sensitivity explains hyperglycemia in patients with acromegaly treated by pasireotide LAR

Wolf Peter , Dormoy Alexandre , Maione Luigi , Salenave Sylvie , Young Jacques , Kamenicky Peter , Chanson Philippe

Background: Pasireotide is a second line treatment for acromegaly. Besides the growth hormone (GH) lowering efficacy, clinical use is limited by side effects on glycemic control. The aim of this study was to evaluate longitudinal changes in beta-cell function and insulin sensitivity induced by pasireotide therapy in patients with acromegaly.Methods: We performed a retrospective study in 33 patients. Efficacy (GH and IGF-I concentrations; tumor size) and ...

ea0041gp163 | Pituitary - Clinical (1) | ECE2016

Medical treatment of macroprolactinomas Escalation and de-escalation of dopamine agonist dose

Paepegaey Anne-Cecile , Salenave Sylvie , Kamenicky Peter , Young Jacques , Chanson Philippe

Background: Cabergoline (CAB) is the most effective dopamine agonist (DA) used for the treatment of macroprolactinoma. Few data on the dose of CAB necessary for achieving and maintaining normal prolactin (PRL) levels are available. We aimed to study these parameters in a large series of patients with macroprolactinomasMethods: We retrospectively analysed the clinical, biochemical and imaging features at diagnosis and the treatment response to CAB (dose n...

ea0022oc4.4 | Adrenals | ECE2010

Combined anticortisolic therapy by metyrapone, ketoconazole and mitotane: an alternative to adrenalectomy in severe Cushing’s syndrome

Kamenicky Peter , Droumaguet Celine , Baudin Eric , Salenave Sylvie , Trabado Severine , Cazabat Laure , Chanson Philippe , Young Jacques

Context: Mitotane due to its adrenolytic action is highly effective in long-term management of ACTH-dependent Cushing’s syndrome (CS). However, the slow onset of its anticortisolic effect makes its use problematic in severe CS, when very rapid therapeutic response is required. Association with metyrapone and ketoconazole, rapidly acting steroidogenesis inhibitors, could warrant CS control while waiting for the full efficiency of mitotane and thus avoid urgently performed ...

ea0090p572 | Calcium and Bone | ECE2023

Similarities and differences between thyroid and parathyroid nodules on ultrasound: the PARATH-US study

Yazgi Dolly , Richa Carine , Salenave Sylvie , Kamenicky Peter , Bourouina Amel , Clavier Lorraine , Young Jacques , Chanson Philippe , Maione Luigi

Context: Cervical ultrasound is a frequently used and an accessible operator-dependent tool, which contributes to the characterization of thyroid nodules and to the preoperative localization of pathological parathyroid glands. However, thyroid nodules may be confused with parathyroid lesions. There is no study directly comparing thyroid and parathyroid nodules on ultrasound.Objectives: 1) To describe the ultrasonographic characteristics of parathyroid le...

ea0035p140 | Calcium and Vitamin D metabolism | ECE2014

Prospective evaluation of endocrine complications in adults with X-linked hypophosphatemic rickets

Kamenicky Peter , Boros Emese , Rothenbuhler Anya , Brailly Sylvie , Silve Caroline , Souberbielle Jean-Claude , Chanson Philippe , Linglart Agnes

Objectives: X-linked hypophosphatemic Rickets (XLHR) is characterized by phosphate wasting and decreased production of 1,25OH-vitamin D, due, in most patients, to elevated FGF23 and PHEX mutation. In children, the disease has been extensively studied because of the devastating presentation of rickets, teeth abcesses, and growth retardation. In adults, however, metabolic complications, such as hyperparathyroidism or consequences on glucose and lipid metabolism of FGF23 excess, ...

ea0099oc2.4 | Oral Communications 2: Calcium and Bone | Part I | ECE2024

Increased urinary excretion of calcium and nephrolithiasis: Real-life data from the epi-hypo cohort of hypoparathyroidism patients

Jean-Philippe Bertocchio , Christelle Nidercorn , Kamenicky Peter , Marie Christine Vantyghem , Gerard Maruani , Groussin Lionel , Ovize Michel , Linglart Agnes , Houillier Pascal

Introduction: In chronic hypoparathyroidism (cHP), hypercalciuria is frequent, the mechanism of which remains unclear. The repetition of episodes of urinary tract obstruction by lithiasis can play a key role in the progressive deterioration of renal function. Taking advantage of the prospective cohort Epi-Hypo, we examined the relationship between nephrolithiasis and hypercalciuria.Methods: The Epi-Hypo cohort started in 2016 in France and is still activ...

ea0099oc2.5 | Oral Communications 2: Calcium and Bone | Part I | ECE2024

Remaining secretion of parathyroid hormone is associated with calcium excretion in chronic hypoparathyroidism

Jean-Philippe Bertocchio , Christelle Nidercorn , Kamenicky Peter , Marie Christine Vantyghem , Gerard Maruani , Groussin Lionel , Ovize Michel , Linglart Agnes , Houillier Pascal

Introduction: In Chronic hypoparathyroidism (cHP), secretion of parathyroid hormone (PTH) is insufficient to maintain blood calcium concentration (PCa) steady. More than 70% of cases result from neck surgery and therefore in insufficient secretion of PTH as in mutations of genes involved in PTH synthesis, while mutations of the calcium-sensing receptor (CaSR) and its signaling pathway may result in a remaining secretion of PTH. cHP can exert nephrocalcinosis and/or nephrolithi...

ea0081p671 | Pituitary and Neuroendocrinology | ECE2022

Targeting invasive pituitary adenomas: in vitro studies and in vivo investigations in a murine model of invasive pituitary tumors obtained by orthotopic pituitary GC cells injection

Chasseloup Fanny , Lefevre Etienne , Dormoy Alexandre , Ladurelle Nataly , Mignot Tiphaine , Janot Clement , Hage Mirella , Viengchareun Say , Zizzari Philippe , Chanson Philippe , Buchfelder Michael , Kamenicky Peter

Context: Surgical removal is the primary treatment option for pituitary adenomas. However, pituitary surgery is frequently incomplete because of invasion of extrasellar cerebral structures, notably, of the cavernous sinus. Our objective was to study the molecular basis of the cavernous sinus invasion by pituitary adenomas.Methods: We analyzed a tissue collection of 19 invasive pituitary adenomas with a sample from the intrasellar portion and a sample fro...

ea0090p2 | Adrenal and Cardiovascular Endocrinology | ECE2023

Pivotal Role of miRNAs during Establishment of the Mineralocorticoid Signaling Pathway and Kidney Development

Imene Hani , Thi An VU , Riwan Brillet , Julie Perrot , Bouligand Jerome , Justine Guegan , Cherradi Nadia , Kamenicky Peter , Marc Lombes , Laetitia Martinerie , Viengchareun Say

The Mineralocorticoid Receptor (MR, NR3C2) mediates sodium-retaining action of aldosterone. Recently, we have shown that the physiological sodium loss observed in newborns in their first days of life is due to a low renal MR expression. However, the underlying molecular mechanisms remain unknown to date. In the adult renal KC3AC1 cell line, we demonstrated that variations in extracellular tonicity, which exist in the nephron, modulate MR expression by posttranscriptio...